{"FDA": "Food and Drug Administration", "FBDD": "Fragment-based drug discovery", "PROTAC": "Proteolysis-targeting chimera", "PROTACs": "Proteolysis-targeting chimeras", "UPS": "ubiquitin-proteasome system", "C1EI": "C1 esterase inhibitor", "PMO": "phosphorodiamidate morpholino antisense oligonucleotide", "CES": "Cat eye syndrome", "mNSCLC": "metastatic non-small cell lung cancer", "PD-L1": "programmed death-ligand 1", "TPS": "tumor proportion score", "EGFR": "epidermal growth factor receptor", "ALK": "anaplastic lymphoma kinase", "ASGPR": "asialoglycoprotein receptor", "RNAP": "RNA polymerase", "RNAPs": "RNA polymerases", "pol II": "polymerase II", "AS": "Alternative splicing", "ERFE": "erythroferrone", "CK": "creatine kinase", "ALBI": "albumin-bilirubin", "PoPH": "portopulmonary hypertension", "mALBI": "modified albumin-bilirubin", "BMI": "body mass index", "CNS": "central nervous system", "COVID-19": "Coronavirus Disease 2019", "RBD": "receptor-binding domain", "Xist": "X-inactive specific transcript", "NMOSD": "Neuromyelitis Optica Spectrum Disorders", "AQP4": "aquaporin-4", "IgG": "immunoglobulin G", "NMO": "Neuromyelitis optica", "IL-6": "interleukin 6", "GFAP": "glial fibrillary acidic protein", "LGG": "Lower grade glioma", "LGGs": "Lower grade gliomas", "IDH": "isocitrate dehydrogenase", "WHO": "World Health Organization", "OT": "Oligodendroglial tumours", "OPC": "oligodendrocyte precursor cell", "DIC": "disseminated intravascular coagulation", "CI": "confidence interval", "FCoV": "feline coronavirus", "FIP": "Feline Infectious Peritonitis", "FeIFN-omega": "Feline interferon-omega", "PPF": "Propentofylline", "3CLpro": "3C-like protease", "RNAi": "RNA interference", "Mutian X": "Mutian\u00ae Xraphconn"}